VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 18 filers reported holding VASCULAR BIOGENICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $32 | -99.9% | 264,500 | -20.5% | 0.00% | – |
| Q3 2022 | $52,000 | -65.8% | 332,600 | +338.8% | 0.00% | – |
| Q1 2021 | $152,000 | -84.5% | 75,800 | -85.4% | 0.00% | -100.0% |
| Q4 2020 | $979,000 | +30.9% | 518,200 | -15.5% | 0.00% | 0.0% |
| Q3 2020 | $748,000 | -3.1% | 613,047 | +1.6% | 0.00% | 0.0% |
| Q2 2020 | $772,000 | +295.9% | 603,133 | +317.1% | 0.00% | – |
| Q1 2020 | $195,000 | +353.5% | 144,600 | +306.0% | 0.00% | – |
| Q4 2019 | $43,000 | +65.4% | 35,615 | +81.6% | 0.00% | – |
| Q3 2019 | $26,000 | -42.2% | 19,612 | -43.8% | 0.00% | – |
| Q2 2019 | $45,000 | +114.3% | 34,900 | +149.3% | 0.00% | – |
| Q1 2019 | $21,000 | -70.8% | 14,000 | -68.5% | 0.00% | – |
| Q3 2018 | $72,000 | – | 44,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,593,286 | $4,382,000 | 1.02% |
| Telemetry Investments, L.L.C. | 75,000 | $127,000 | 0.20% |
| Ikarian Capital, LLC | 830,747 | $1,404,000 | 0.18% |
| DLD Asset Management, LP | 550,000 | $930,000 | 0.06% |
| Phoenix Holdings Ltd. | 1,020,000 | $1,724,000 | 0.03% |
| Spectrum Planning & Advisory Services Inc. | 16,000 | $27,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 79,716 | $135,000 | 0.00% |
| HBK Sorce Advisory LLC | 22,325 | $38,000 | 0.00% |
| B. Riley Wealth Management, Inc. | 12,000 | $20,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 12,155 | $21,000 | 0.00% |